Boland Melinde R S, Tsiachristas Apostolos, Kruis Annemarije L, Chavannes Niels H, Rutten-van Mölken Maureen P M H
Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands • Department of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Prim Care Respir J. 2014 Mar;23(1):30-7. doi: 10.4104/pcrj.2014.00002.
To investigate the association of the GOLD ABCD groups classification with costs and health-related quality of life (HR-QoL) and to compare this with the GOLD 1234 grades classification that was primarily based on lung function only.
In a cross-sectional study, we selected patients diagnosed with chronic obstructive pulmonary disease (COPD) from electronic medical records of general practices. Multi-level analysis was used with costs (medication, primary care, healthcare, societal), diseasespecific and generic HR-QoL as independent variables. Either the new or the old GOLD stages were included in the analysis together with several covariates (age, gender, living situation, co-morbidity, self-efficacy, smoking, education, employment).
611 patients from 28 general practices were categorised as GOLD-A (n=333), GOLD-B (n=110), GOLD-C (n=80) and GOLD-D (n=88). Patients in the GOLD-B and GOLD-D groups had the highest prevalence of co-morbidities and the lowest level of physical activity, self-efficacy, and employment. The models with GOLD ABCD groups were more strongly related to and explained more variance in costs and in disease-specific and generic HR-QoL than the models with GOLD 1234 grades. The mean Clinical COPD Questionnaire score worsened significantly, with scores 1.04 (GOLD-B), 0.4 (GOLD-C) and 1.21 (GOLD-D) worse than for patients in GOLD-A. Healthcare costs per patient were significantly higher in GOLD-B (72%), GOLD-C (74%) and GOLD-D (131%) patients than in GOLD-A patients.
The GOLD ABCD groups classification is more closely associated with costs and HR-QoL than the GOLD 1234 grades classification. Furthermore, patients with GOLD-C had a better HR-QoL than those with GOLD-B but the costs of the two groups did not differ.
研究慢性阻塞性肺疾病全球倡议(GOLD)ABCD组分类与成本及健康相关生活质量(HR-QoL)之间的关联,并将其与主要仅基于肺功能的GOLD 1234级分类进行比较。
在一项横断面研究中,我们从全科医疗的电子病历中选取被诊断为慢性阻塞性肺疾病(COPD)的患者。采用多水平分析,将成本(药物治疗、初级保健、医疗保健、社会成本)、疾病特异性和通用HR-QoL作为自变量。分析中纳入新的或旧的GOLD分期以及几个协变量(年龄、性别、生活状况、合并症、自我效能感、吸烟、教育程度、就业情况)。
来自28家全科医疗的611名患者被分类为GOLD-A组(n = 333)、GOLD-B组(n = 110)、GOLD-C组(n = 80)和GOLD-D组(n = 88)。GOLD-B组和GOLD-D组患者的合并症患病率最高,身体活动、自我效能感和就业水平最低。与采用GOLD 1234级的模型相比,采用GOLD ABCD组的模型与成本以及疾病特异性和通用HR-QoL的相关性更强,且能解释更多的方差。慢性阻塞性肺疾病临床问卷平均得分显著恶化,GOLD-B组(得分比GOLD-A组差1.04)、GOLD-C组(差0.4)和GOLD-D组(差1.21)。GOLD-B组(高72%)、GOLD-C组(高74%)和GOLD-D组(高131%)患者的人均医疗保健成本显著高于GOLD-A组患者。
GOLD ABCD组分类与成本及HR-QoL的关联比GOLD 1234级分类更为密切。此外,GOLD-C组患者的HR-QoL优于GOLD-B组患者,但两组的成本没有差异。